Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.70 |
| ▸ | HPGD | P15428 | 4/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | GLA | P06280 | 1/20 | 0.68 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.51 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.51 |
| ▸ | GGT1 | P19440 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benorilate SCHEMBL27446831 | 1.00 | HSD17B10 (0.70) | HSD17B10HPGDALDH1A1KDM4EGLA | |
| Benorilate SCHEMBL15526470 | 1.00 | HSD17B10 (0.70) | HSD17B10HPGDALDH1A1KDM4EGLA | |
| Benorilate SCHEMBL15969775 | 0.99 | HSD17B10 (0.68) | HSD17B10HPGDALDH1A1KDM4EGLA | |
| Benorilate SCHEMBL1162333 | 0.95 | HSD17B10 (0.68) | HSD17B10HPGDALDH1A1KDM4EGLA | |
| Benorilate SCHEMBL28324024 | 0.91 | HSD17B10 (0.60) | HSD17B10HPGDALDH1A1KDM4EGLA | |
| Benorilate SCHEMBL28086366 | 0.89 | MAPK1 (0.61) | HSD17B10HPGDALDH1A1KDM4EGLA | |
| SCHEMBL13243355 | 0.89 | HPGD (0.70) | HSD17B10HPGDALDH1A1KDM4EGLA | |
| Benorilate SCHEMBL28008209 | 0.88 | PTGS2 (0.59) | HSD17B10HPGDALDH1A1KDM4EGLA | |
| SCHEMBL29277083 | 0.85 | PTGS2 (0.55) | HSD17B10HPGDALDH1A1KDM4EGLA | |
| SCHEMBL11320907 | 0.84 | HPGD (0.57) | HSD17B10HPGDALDH1A1KDM4EGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11695 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20260069532-A1 | METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE | MEDINCELL S.A. (FR) | 2026-03-12 | — | — | US | claimed |
| US-12558309-B2 | Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue | MEDINCELL S.A. (FR) | 2026-02-24 | — | — | US | claimed |
| EP-4482481-B1 | COMPOUNDS FOR USE IN THE TREATMENT OF DYSTROPHINOPATHIES | SOM INNOVATION BIOTECH S A (ES) | 2025-11-12 | — | — | EP | claimed |
| WO-2025224317-A1 | A METHOD FOR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLE IN TOTAL KNEE REPLACEMENT | MEDINCELL S.A. (FR) | 2025-10-30 | — | — | WO | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-20250152567-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF DYSTROPHINOPATHIES | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2025-05-15 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| CN-119770461-A | Preparation method of amphiphilic high-amylose corn grafted starch nanofiber drug-loaded membrane | 安徽工程大学 | 2025-04-08 | — | — | CN | claimed |
| EP-0268388-B1 | ANTI-INFLAMMATORY COMPOSITIONS | GLAXO GROUP LIMITED (GB) | 1992-07-22 | — | — | EP | claimed |
| US-4855293-A | Anti-inflammatory compositions comprising a systemic non-steroidal anti-inflammatory drug and a cyclopentyl ether | GLAXO GROUP LIMITED (GB) | 1989-08-08 | — | — | US | claimed |
| EP-0100168-B1 | PROCESSES FOR PREPARING TABLETS BY A MODIFIED 'WET-GRANULATION' TECHNIQUE | Rogerson, Alan George (GB) | 1988-12-28 | — | — | EP | claimed |
| EP-0268388-A1 | Anti-inflammatory compositions | GLAXO GROUP LIMITED (GB) | 1988-05-25 | — | — | EP | claimed |
| CN-85109571-A | The method of one-step synthesis antirheumatic benoral | — | 1987-07-08 | — | — | CN | claimed |
| EP-0093520-B1 | PHARMACEUTICAL COMPOSITIONS AND PREPARATION THEREOF | NORISTAN LIMITED (ZA) | 1986-10-15 | — | — | EP | claimed |
| US-4562024-A | HOMOGENIZING PART OF SOLID WITH GRANULATING FLUID TO FORM UNIFORM SLURRY, MOISTENING REST OF SOLID WITH SLURRY FORMED | STERLING DRUG INC. (US) | 1985-12-31 | — | — | US | claimed |
| EP-0100168-A2 | Processes for preparing tablets by a modified 'wet-granulation' technique | Rogerson, Alan George (GB) | 1984-02-08 | — | — | EP | claimed |
| EP-0093520-A1 | Pharmaceutical compositions and preparation thereof | NORISTAN LIMITED (ZA) | 1983-11-09 | — | — | EP | claimed |
| US-4378354-A | CONSISTING OF A PHOSPHOLIPID AND SALICYLIC ACID OR DERIVATIVE | A. NATTERMANN & CIE. GMBH (DE) | 1983-03-29 | — | — | US | claimed |